Medline Inc. (MDLN)
Nasdaq · Healthcare · Medical Instruments & Supplies
$35.80+0.53%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $48.2B
- P/E (trailing)
- 89.5
- Forward P/E
- 22.7
- 52-week range
- $31.49 – $50.88
- 52-week change
- −13.15%
- EPS (trailing)
- $0.40
- Analyst rating
- 1.6 Buy
- Next earnings
- Nov 4, 2026
Fiscal year to Dec 2025
- Revenue
- $28.4B (+11.47%)
- Net income
- $1.16T
- Operating margin
- 7.8%
- Diluted EPS
- −$0.01
- Free cash flow
- $1.3B
From the company’s annual report on SEC EDGAR.
About Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants.
Headquarters: Northfield, United States · 45,000 employees · medline.com